A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Overall ranking Vacancies Funding Methodology Key Finding

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

14 Nov 2016

Big pharma is failing to do enough for poor countries

Gonzalo Viña covers the 2016 Access to Medicine Index for the Financial Times. He focuses on the companies ranked in the lower half of the Index, and...

14 Nov 2016

GSK tops list of drug firms improving global access to medicine

Julia Kollewe reports on how GSK can lead the Access to Medicine Index for the fifth time in 2016, while its British peer AstraZeneca climbs into the...

14 Nov 2016

Drug firms need to tackle affordability

Anne Gulland reports on the 2016 Access to Medicine Index for the BMJ, covering the ranking itself and the main findings from the Index report.

14 Nov 2016

Pharmaindustrie tut zu wenig in der Dritten Welt

Patrick Griesser reports on the 2016 Access to Medicine Index, focusing on affordability and R&D pipelines (article in German).

14 Nov 2016

Access To Medicine Index Finds Progress In Pharma’s Efforts

Writing for Intellectual Property Watch, Catherine Saez reports on the main findings of the 2016 Access to Medicine Index, focusing on its overal anal...

14 Nov 2016

Drugmakers improve access for poor, GSK ranked top

Ben Hirschler and Mark Potter report on the 2016 Access to Medicine Index for Reuters, highlighting how the Index can focus executives’ attention on t...

14 Nov 2016

Volop kansen voor farmaceutische bedrijven in arme landen

Henk Snyders reports on the 2016 Access to Medicine Index, with a focus on affordability of medicines (article in Dutch).

14 Nov 2016

Grote farmaceuten doen meer voor armen

Ellen de Visser reports on the 2016 Access to Medicine Index (article in Dutch).

14 Nov 2016

Pharmaindustrie engagiert sich mehr in Entwicklungsländern

Writing for WirtschaftsWoche, Germany's weekly business magazine, Jürgen Salz reports on the results of the 2016 Access to Medicine Index. T...

13 Nov 2016

Dure pillen doen ons nu allemaal pijn

Karel Berkhout interviews Jayasree K. Iyer, Executive Director, Access to Medicine Foundation on the impact of availability and affordability of medi...

13 Nov 2016

Which drug makers do a good job getting poor patients access to their medicines?

In the Pharmalot column, Ed Silverman reports on the companies at the top of the 2016 Access to Medicine Index, quoting Foundation Executive Director,...

13 Nov 2016

Which Big Drug Companies Are Helping the Poor? Here’s the List

Donald G McNeil Jr covers the 2016 Access to Medicine Index, with a focus on the power of company CEO’s to set the pace of change.

13 Nov 2016

New Pharma Rankings On Global Access To Medicine Released

Judy Stone reports on the 2016 Access to Medicine Index and refers to some of the main findings, namely those related to R&D, Pricing and Governance &...

13 Nov 2016

Meer beleggers willen goedkope medicijnen voor de armen

Karel Berkhout reports on the 2016 Access to Medicine Index, describing the importance of the ranking for responsible investors (article in Dutch).

06 Sep 2016

Jayasree K. Iyer among experts consulted for Fortune’s ‘Change the World’ list

Jayasree K. Iyer, Executive Director at the Access to Medicine Foundation was amongst the experts consulted by the team at Fortune magazine for their...

23 Aug 2016

Access to Medicine Index mentioned in an article in Neue Zürcher Zeitung

In the article titled ‘Teure Medikamente erhöhen den Druck’, guest columnist Simon Schmid writes about pricing, patents and licencing and their inteco...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.